Publications by authors named "Elias Jabbour"

100Publications

CD123 Expression in Philadelphia Chromosome-like B Acute Lymphoblastic Leukemia/Lymphoma.

Clin Lymphoma Myeloma Leuk 2020 Oct 8. Epub 2020 Oct 8.

Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2020.09.014DOI Listing
October 2020

Cancer and COVID-19.

Lancet 2020 10;396(10257):1066-1067

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(20)32070-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544468PMC
October 2020

Intensive Versus Non-Intensive Approach to Adults with Ph+ ALL: An Intensive Approach Is Still Standard of Care.

Clin Lymphoma Myeloma Leuk 2020 Sep;20 Suppl 1:S52-S53

The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2152-2650(20)30460-2DOI Listing
September 2020

Management of Older Patients with Acute Lymphocytic Leukemia - Novel Treatment Strategies.

Clin Lymphoma Myeloma Leuk 2020 Sep;20 Suppl 1:S30-S31

The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2152-2650(20)30452-3DOI Listing
September 2020

Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies.

Ann Hematol 2020 Oct 27;99(10):2215-2229. Epub 2020 Aug 27.

Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-020-04221-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481145PMC
October 2020

Nelarabine-related rhabdomyolysis in a patient with T-cell acute lymphoblastic leukemia.

Leuk Lymphoma 2020 Nov 11;61(11):2775-2777. Epub 2020 Jul 11.

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2020.1791852DOI Listing
November 2020

Gilteritinib in the treatment of relapsed and refractory acute myeloid leukemia with a FLT3 mutation.

Ther Adv Hematol 2020 3;11:2040620720930614. Epub 2020 Jun 3.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 428, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620720930614DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271272PMC
June 2020

High levels of immunoglobulin expression predict shorter overall survival in patients with acute myeloid leukemia.

Eur J Haematol 2020 Jun 14. Epub 2020 Jun 14.

Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13466DOI Listing
June 2020

Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions.

J Hematol Oncol 2020 06 5;13(1):70. Epub 2020 Jun 5.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-020-00905-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275444PMC
June 2020

Outcome of adults with relapsed/refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma.

Am J Hematol 2020 Jun 5. Epub 2020 Jun 5.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25896DOI Listing
June 2020

Recent Advances in Managing Acute Lymphoblastic Leukemia.

Am Soc Clin Oncol Educ Book 2020 May;40:330-342

Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_280175DOI Listing
May 2020

Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities.

Clin Lymphoma Myeloma Leuk 2020 Sep 20;20(9):e597-e605. Epub 2020 Mar 20.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2020.03.005DOI Listing
September 2020

Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring.

Am J Hematol 2020 06 10;95(6):691-709. Epub 2020 Apr 10.

Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25792DOI Listing
June 2020

Evaluation and management of measurable residual disease in acute lymphoblastic leukemia.

Ther Adv Hematol 2020 6;11:2040620720910023. Epub 2020 Mar 6.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 428, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620720910023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065280PMC
March 2020

Disseminated cytomegalovirus infection with bilateral adrenal pseudotumors masquerading as recurrent hematologic malignancy.

Infection 2020 Jun 6;48(3):477-481. Epub 2020 Mar 6.

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s15010-020-01404-9DOI Listing
June 2020

FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions.

Leukemia 2020 03 9;34(3):682-696. Epub 2020 Jan 9.

Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0694-3DOI Listing
March 2020

Treatment-free remission in chronic myeloid leukemia.

Clin Adv Hematol Oncol 2019 Dec;17(12):686-696

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
December 2019

The face of remission induction.

Br J Haematol 2020 01 12;188(1):101-115. Epub 2019 Dec 12.

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16353DOI Listing
January 2020

Optimizing the use of the hyperCVAD regimen: Clinical vignettes and practical management.

Cancer 2020 03 3;126(6):1152-1160. Epub 2019 Dec 3.

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32606DOI Listing
March 2020

The role of cladribine in acute myeloid leukemia: an old drug up to new tricks.

Leuk Lymphoma 2020 03 22;61(3):536-545. Epub 2019 Nov 22.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1672060DOI Listing
March 2020

Complexity of chronic-phase CML management after failing a second-generation TKI.

Leuk Lymphoma 2020 04 18;61(4):776-787. Epub 2019 Nov 18.

The University of Texas MD Anderson Cancer Center, LEUKEMIA, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1691196DOI Listing
April 2020

Sudden blastic transformation in treatment-free remission chronic myeloid leukaemia.

Br J Haematol 2019 11 4;187(4):543-545. Epub 2019 Oct 4.

Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16245DOI Listing
November 2019

Targeted therapy paves the way for the cure of acute lymphoblastic leukaemia.

Br J Haematol 2020 01 30;188(2):207-223. Epub 2019 Sep 30.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16207DOI Listing
January 2020

Maintenance therapy in AML: The past, the present and the future.

Am J Hematol 2019 11 11;94(11):1254-1265. Epub 2019 Sep 11.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25620DOI Listing
November 2019

Therapy Options in Treating Acute Lymphoblastic Leukemia in Adults.

Authors:
Elias Jabbour

Oncology (Williston Park) 2019 07 16;33(7). Epub 2019 Jul 16.

View Article

Download full-text PDF

Source
July 2019

SOHO State of the Art Update and Next Questions: Advances in the Treatment of Adult Acute Lymphoblastic Leukemia.

Clin Lymphoma Myeloma Leuk 2019 08 3;19(8):471-479. Epub 2019 Jul 3.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.06.011DOI Listing
August 2019

Reply to Mini-HCVD plus inotuzumab plus or minus blinatumomab: Hype or hope?

Cancer 2019 11 10;125(21):3891-3892. Epub 2019 Jul 10.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32385DOI Listing
November 2019

Neurotoxic events associated with BCR-ABL1 tyrosine kinase inhibitors: a case series.

Leuk Lymphoma 2019 12 27;60(13):3292-3295. Epub 2019 Jun 27.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1633635DOI Listing
December 2019

Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemia.

Ther Adv Hematol 2019 19;10:2040620719849496. Epub 2019 May 19.

Department of Leukemia, Unit 428, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620719849496DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535741PMC
May 2019

Ibrutinib and Venetoclax for First-Line Treatment of CLL.

N Engl J Med 2019 05;380(22):2095-2103

From the Departments of Leukemia (N.J., M. Keating, P.T., A.F., J.B., G.B., K.T., Z.E., T.K., M. Konopleva, Y.A., M.Y., C.D., P.B., M.O., N.P., E.J., K. Sasaki, K. Sondermann, N.C., C.W., A.A., H.K., W.W.), Lymphoma and Myeloma (N.F.), Hematopathology (R.K.-S., K.P., J.J.), Diagnostic Radiology (N.G.), Biostatistics (X.W.), and Experimental Therapeutics (W.P., V.G.), University of Texas M.D. Anderson Cancer Center, Houston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1900574DOI Listing
May 2019

Recent advances in the treatment of acute lymphoblastic leukemia.

Leuk Lymphoma 2019 11 16;60(11):2606-2621. Epub 2019 May 16.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1605071DOI Listing
November 2019

Economic modeling to evaluate the impact of chronic myeloid leukemia therapy management on the oncology care model in the US.

J Med Econ 2019 Nov 31;22(11):1113-1118. Epub 2019 May 31.

Bristol-Myers Squibb , Princeton , NJ , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13696998.2019.1618316DOI Listing
November 2019

Development of a symptom assessment in patients with myelofibrosis: qualitative study findings.

Health Qual Life Outcomes 2019 Apr 11;17(1):61. Epub 2019 Apr 11.

Guy's and St. Thomas' NHS Foundation Trust, St. Thomas Hospital, Westminster Bridge Rd. Lambeth, London, SE1 7EH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12955-019-1121-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460742PMC
April 2019

Treatment of relapsed/refractory acute lymphoblastic leukemia.

Clin Adv Hematol Oncol 2019 Mar;17(3):166-175

University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
March 2019

Recent Advances in Adult Acute Lymphoblastic Leukemia.

Curr Hematol Malig Rep 2019 04;14(2):106-118

Department of Leukemia, University of Texas, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 428, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-019-00503-1DOI Listing
April 2019